282 related articles for article (PubMed ID: 30902482)
1. A systematic review of vaccine preventable disease surveillance cost studies.
Erondu NA; Ferland L; Haile BH; Abimbola T
Vaccine; 2019 Apr; 37(17):2311-2321. PubMed ID: 30902482
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016.
Charania NA; Gaze N; Kung JY; Brooks S
Vaccine; 2019 May; 37(20):2661-2669. PubMed ID: 30967311
[TBL] [Abstract][Full Text] [Related]
3. Vaccine preventable diseases surveillance in Nepal: How much does it cost?
Huang XX; Bose AS; Gupta BP; Rai P; Joshi S; Gautam JS; Tinkari BS; Vandelaer J; Cohen AL; Patel MK
Vaccine; 2021 Sep; 39(40):5982-5990. PubMed ID: 34419305
[TBL] [Abstract][Full Text] [Related]
4. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
[TBL] [Abstract][Full Text] [Related]
5. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE
PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
[TBL] [Abstract][Full Text] [Related]
7. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy A; Clark RA; Quaife M; Weerasuriya CK; Mukandavire C; Bakker R; Deol AK; Malhotra S; Gebreselassie N; Zignol M; Sim SY; Hutubessy RCW; Baena IG; Nishikiori N; Jit M; White RG; Menzies NA
PLoS Med; 2023 Jan; 20(1):e1004155. PubMed ID: 36693081
[TBL] [Abstract][Full Text] [Related]
8. Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020.
Bigouette JP; Callaghan AW; Donadel M; Porter AM; Rosencrans L; Lickness JS; Blough S; Li X; Perry RT; Williams AJ; Scobie HM; Dahl BA; McFarland J; Murrill CS
Emerg Infect Dis; 2022 Dec; 28(13):S203-S207. PubMed ID: 36502406
[TBL] [Abstract][Full Text] [Related]
9. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.
Baral R; Nonvignon J; Debellut F; Agyemang SA; Clark A; Pecenka C
BMC Public Health; 2020 May; 20(1):619. PubMed ID: 32370763
[TBL] [Abstract][Full Text] [Related]
10. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
[TBL] [Abstract][Full Text] [Related]
11. Expenditures on vaccine-preventable disease surveillance: Analysis and evaluation of comprehensive multi-year plans (cMYPs) for immunization.
Hossain A; Politi C; Mandalia N; Cohen AL
Vaccine; 2018 Oct; 36(45):6850-6857. PubMed ID: 30236633
[TBL] [Abstract][Full Text] [Related]
12. Entangled epidemics: tackling vaccine-preventable diseases in the era of frequent epidemics in Africa.
Kouamou V; Inzaule S
Pan Afr Med J; 2023; 46():32. PubMed ID: 38145199
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Vaccine-Preventable Disease Surveillance in the Western Pacific Region: A Literature Review on Integration of Surveillance Functions, 2000-2021.
Donadel M; Scobie HM; Pastore R; Grabovac V; Batmunkh N; O'Connor S; Dahl BA; Murrill CS
Glob Health Sci Pract; 2022 Oct; 10(5):. PubMed ID: 36316133
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-preventable diseases other than tuberculosis, and homelessness: A scoping review of the published literature, 1980 to 2020.
Ly TDA; Castaneda S; Hoang VT; Dao TL; Gautret P
Vaccine; 2021 Feb; 39(8):1205-1224. PubMed ID: 33509694
[TBL] [Abstract][Full Text] [Related]
15. Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies.
de Broucker G; Sim SY; Brenzel L; Gross M; Patenaude B; Constenla DO
Pharmacoeconomics; 2020 Oct; 38(10):1071-1094. PubMed ID: 32748334
[TBL] [Abstract][Full Text] [Related]
16. Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review.
Berrueta M; Ciapponi A; Bardach A; Cairoli FR; Castellano FJ; Xiong X; Stergachis A; Zaraa S; Meulen AS; Buekens P;
BMC Pregnancy Childbirth; 2021 Mar; 21(1):217. PubMed ID: 33731029
[TBL] [Abstract][Full Text] [Related]
17. Cost of maternal health services in low and middle-income countries: protocol for a systematic review.
Banke-Thomas A; Abejirinde IO; Banke-Thomas O; Maikano A; Ameh CA
BMJ Open; 2019 Aug; 9(8):e027822. PubMed ID: 31434768
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.
Malhotra A; Thompson RR; Kagoya F; Masiye F; Mbewe P; Mosepele M; Phiri J; Sambo J; Barker A; Cameron DB; Davila-Roman VG; Effah W; Hutchinson B; Laxy M; Newsome B; Watkins D; Sohn H; Dowdy DW
Implement Sci; 2022 Nov; 17(1):76. PubMed ID: 36384807
[TBL] [Abstract][Full Text] [Related]
19. Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review.
Ekwunife OI; Grote AG; Mosch C; O'Mahony JF; Lhachimi SK
Syst Rev; 2015 May; 4():68. PubMed ID: 25963745
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
